Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Registry for ME/CFS, Including ME/CFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)

NCT05778006 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT05778006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05778006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Registry for ME/CFS, Including ME/CFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)
Lead sponsor
Technical University of Munich
Phase
Observational
Overall status
Recruiting
Start date
May 31, 2022
Completion date
May 31, 2052
Enrollment
650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cfs/me, me/cfs, me/cfs following covid-19, me/cfs following ebv-associated infectious mononucleosis